{
    "paper_id": "e11bd83bc9ade0e9b52c309828a96cc4214d55c4",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "Luis",
                "middle": [
                    "G"
                ],
                "last": "Berm\u00fadez-Humar\u00e1n",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Philippe",
                "middle": [],
                "last": "Langella",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. TH\u00c9MATIQUE \u00c0 TAPER \u00c9VOLUTIONS R\u00c9CENTES EN MICROBIOLOGIE REVUE FRANCOPHONE DES LABORATOIRES -D\u00c9CEMBRE 2009 -N\u00b0417 // 79 Utilisation des bact\u00e9ries lactiques comme vecteurs vaccinaux a INRA 0910 -Unit\u00e9 d'\u00e9cologie et de physiologie du syst\u00e8me digestif 78352 Jouy-en-Josas * Correspondance philippe.langella@jouy.inra.fr article re\u00e7u le 17 septembre, accept\u00e9 le 12 octobre 2009. \u00a9 2009 -Elsevier Masson SAS -Tous droits r\u00e9serv\u00e9s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Aujourd'hui, nous disposons de donn\u00e9es suffi santes qui confortent l'int\u00e9r\u00eat d'utiliser des bact\u00e9ries lactiques (BL), notamment des souches des lactocoques et lactobacilles, pour le d\u00e9veloppement de nouvelles strat\u00e9gies de vaccination mucosale. Les BL sont des bact\u00e9ries \u00e0 Gram positif utilis\u00e9es depuis des mill\u00e9naires dans la production d'aliments ferment\u00e9s. Elles sont donc de bonnes candidates pour le d\u00e9veloppement de nouvelles strat\u00e9gies de vectorisation orale et constituent des alternatives attractives aux strat\u00e9gies vaccinales bas\u00e9es sur des bact\u00e9ries pathog\u00e8nes att\u00e9nu\u00e9es dont l'utilisation pr\u00e9sente des risques sanitaires. Ce chapitre passe en revue la recherche et les progr\u00e8s les plus r\u00e9cents dans l'utilisation des BL comme vecteurs de d\u00e9livrance de prot\u00e9ines d'int\u00e9r\u00eat m\u00e9dical pour d\u00e9velopper de nouveaux vaccins.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Bact\u00e9ries lactiques -Lactococcus lactis -Lactobacillus spp.vaccins vivants -vecteurs mucosaux -antig\u00e8nes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "SUMMARY",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Today, suffi cient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to produce fermented foods. They are thus good candidates to develop novel oral vectors and constitute attractive alternatives to vaccinal strategies based on attenuated pathogens which could induce healthy risks. Here, we summarized the most recent researches performed on the use of LAB as live vaccine delivery vectors.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Lactic acid bacteria -Lactococcus lactis -Lactobacillus spp. -live vaccinesmucosal vectors -antigenes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Les bact\u00e9ries lactiques (BL) sont des bact\u00e9ries \u00e0 Gram positif qui produisent de l'acide lactique comme produit principal de leur m\u00e9tabolisme. Elles regroupent 12 genres bact\u00e9riens dont les plus \u00e9tudi\u00e9s sont Lactobacillus, Lactococcus, Streptococcus, Enterococcus, Pediococcus et Bifi dobacterium [1] . Les BL sont largement utilis\u00e9es dans des proc\u00e9d\u00e9s industriels de fermentation agro-alimentaire et certains genres comme les lactobacilles ou les bifi dobact\u00e9ries sont des bact\u00e9ries commensales qui font partie du microbiote intestinal [2] . Les BL sont g\u00e9n\u00e9ralement reconnues comme \u00e9tant sans danger par les autorit\u00e9s (microorganismes Generally Recognized As Safe) [3] . Lorsqu'elles sont ing\u00e9r\u00e9es vivantes en grandes quantit\u00e9s, elles peuvent survivre dans le tractus digestif de l'h\u00f4te, o\u00f9 elles sont susceptibles d'exercer diverses actions b\u00e9n\u00e9fiques sur l'h\u00f4te apr\u00e8s leur ingestion (ex. am\u00e9lioration de la digestion des fi bres, stimulation du syst\u00e8me immunitaire et pr\u00e9vention ou traitement des diarrh\u00e9es) [4] . Du fait de leur parfaite innocuit\u00e9 et de leurs effets probiotiques (pour certaines), les BL sont de plus en plus \u00e9tudi\u00e9es pour le d\u00e9veloppement de nouvelles strat\u00e9gies de vaccination mucosale [5] . Actuellement, les vaccins mucosaux en cours de d\u00e9veloppement sont bas\u00e9s sur l'utilisation de microorganismes pathog\u00e8nes att\u00e9nu\u00e9s dont l'utilisation pr\u00e9sente des risques sanitaires [5] . Comme les BL sont inoffensives ou m\u00eame b\u00e9n\u00e9fi ques (certaines esp\u00e8ces), elles repr\u00e9sentent une alternative int\u00e9ressante aux strat\u00e9gies bas\u00e9es sur des pathog\u00e8nes att\u00e9nu\u00e9s pour l'administration mucosale de vaccins ou m\u00e9dicaments [5] . En effet, de tels vecteurs vivants permettent l'induction d'une immunit\u00e9 au niveau des muqueuses qui constituent la premi\u00e8re ligne de d\u00e9fense contre des agents pathog\u00e8nes. De plus, ces vecteurs, plus faciles \u00e0 administrer et moins co\u00fbteux \u00e0 produire que les vaccins injectables, sont tout \u00e0 fait adapt\u00e9s \u00e0 des campagnes massives de vaccination dans les pays en voie de d\u00e9veloppement. effi cace de limiter la morbidit\u00e9 et la mortalit\u00e9 induites par ces agents est la vaccination. Les muqueuses, des tractus gastro-intestinal, respiratoire et urog\u00e9nital, repr\u00e9sentent une surface de contact d'environ 400 m 2 avec le milieu ext\u00e9rieur. Ces surfaces muqueuses comportent un syst\u00e8me immunitaire tr\u00e8s d\u00e9velopp\u00e9 : MALT (mucosa associated lymphoid tissue), constitu\u00e9 d'environ 80 % des cellules immunitaires de l'organisme et consid\u00e9r\u00e9 ainsi comme le plus important syst\u00e8me lympho\u00efde chez l'homme [6, 7] . Ces propri\u00e9t\u00e9s particuli\u00e8res ont suscit\u00e9 l'int\u00e9r\u00eat d'exploiter une approche vaccinale muqueuse pour lutter contre les agents infectieux d\u00e8s leur p\u00e9n\u00e9tration dans l'organisme. Les vaccins muqueux offrent l'avantage d'induire une r\u00e9ponse immunitaire \u00e0 la fois muqueuse et syst\u00e9mique. Au contraire, les vaccins injectables traditionnels g\u00e9n\u00e8rent une bonne immunit\u00e9 syst\u00e9mique mais n'induisent pas ou tr\u00e8s peu d'immunit\u00e9 muqueuse [8] . Les vaccins muqueux sont a priori d\u00e9pourvus d'effets secondaires parce qu'ils \u00e9vitent le contact direct entre les composants complexes des vaccins (ex. adjuvants, potentiellement dangereux), et la circulation syst\u00e9mique. D'un point de vue pratique, ils sont faciles \u00e0 administrer (spray nasal ou par voie orale par exemple), d'un moindre co\u00fbt et donc plus accessibles aux pays en voie de d\u00e9veloppement [8] . Cependant, en d\u00e9pit de ces avantages, l'effi cacit\u00e9 de l'immunisation au niveau des muqueuses est limit\u00e9e par la d\u00e9gradation des antig\u00e8nes, l'adsorption sur les muqueuses de l'h\u00f4te et l'utilisation de syst\u00e8mes d'expression inadapt\u00e9s. Dans les derni\u00e8res ann\u00e9es, de nouvelles strat\u00e9gies d'immunisation par voie mucosale ont \u00e9t\u00e9 d\u00e9velopp\u00e9es sur la base de pathog\u00e8nes att\u00e9nu\u00e9s (bact\u00e9ries et virus) exprimant des mol\u00e9cules d'int\u00e9r\u00eat m\u00e9dical [9] . Cependant, le principal risque li\u00e9 \u00e0 l'utilisation de ces syst\u00e8mes est un retour \u00e0 l'\u00e9tat pathog\u00e8ne de ces microorganismes interdisant leur application \u00e0 des patients immunod\u00e9prim\u00e9s, des personnes \u00e2g\u00e9es et des enfants [10] . L'utilisation de BL en tant que vecteurs d'antig\u00e8nes constitue une strat\u00e9gie plus s\u00fbre et moins on\u00e9reuse. En plus, ces bact\u00e9ries ont d\u00e9j\u00e0 \u00e9t\u00e9 utilis\u00e9es avec succ\u00e8s pour exprimer et d\u00e9livrer plusieurs prot\u00e9ines d'int\u00e9r\u00eat m\u00e9dical [5, 11, 12] .",
            "cite_spans": [
                {
                    "start": 297,
                    "end": 300,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 537,
                    "end": 540,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 667,
                    "end": 670,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1012,
                    "end": 1015,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1210,
                    "end": 1213,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1396,
                    "end": 1399,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1629,
                    "end": 1632,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 2523,
                    "end": 2526,
                    "text": "[6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2527,
                    "end": 2529,
                    "text": "7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 2958,
                    "end": 2961,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 3366,
                    "end": 3369,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 3808,
                    "end": 3811,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 4032,
                    "end": 4036,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 4267,
                    "end": 4270,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 4271,
                    "end": 4274,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 4275,
                    "end": 4278,
                    "text": "12]",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Un vecteur id\u00e9al \u00e0 administration muqueuse doit pouvoir : i) pr\u00e9server les antig\u00e8nes des d\u00e9gradations, ii) cibler le syst\u00e8me immunitaire local (ex. cellules \u00e9pith\u00e9liales ou cellules dendritiques susceptibles de capturer l'antig\u00e8ne) et iii) stimuler de fa\u00e7on appropri\u00e9e l'immunit\u00e9 inn\u00e9e et sp\u00e9cifi que afi n d'induire une immunit\u00e9 sp\u00e9cifi que adapt\u00e9e. Les r\u00e9centes avanc\u00e9es en biotechnologie et une meilleure compr\u00e9hension du syst\u00e8me immunitaire ont rendu possible aujourd'hui la conception des nouveaux vecteurs \u00e0 administration muqueuse [13] . De tels vecteurs comprennent : i) des syst\u00e8mes inertes dans lesquels divers complexes lipidiques, nanoparticules, microsph\u00e8res ou polym\u00e8res solubles enrobent les antig\u00e8nes ou l'ADN nu [14] [15] [16] , ii) des vecteurs viraux (ad\u00e9novirus, virus de la rougeole ou poxvirus) [17] [18] [19] [20] [21] [22] ou des vecteurs bact\u00e9riens tels que des bact\u00e9ries pathog\u00e8nes att\u00e9nu\u00e9es (d\u00e9riv\u00e9s de Salmonella typhi, Bordetella pertussis, etc.) ou des bact\u00e9ries lactiques et/ou commensales [5, 11, 12, 23, 24] (tableau I). Toutefois, les vecteurs viraux et bact\u00e9riens sont plus immunog\u00e9niques que les vecteurs inertes et repr\u00e9sentent donc de meilleurs candidats pour induire une r\u00e9ponse immunitaire muqueuse et syst\u00e9mique. Parmi ces deux types de vecteurs \u00e0 administration muqueuse (virus et bact\u00e9ries), les g\u00e9nomes bact\u00e9riens pr\u00e9sentent l'avantage de pouvoir contenir plusieurs g\u00e8nes h\u00e9t\u00e9rologues \u00e0 la diff\u00e9rence des vecteurs viraux dont le nombre des g\u00e8nes h\u00e9t\u00e9rologues est limit\u00e9 par la taille de son g\u00e9nome beaucoup plus petit que les vecteurs bact\u00e9riens. Ainsi, une bact\u00e9rie recombinante peut produire diff\u00e9rents antig\u00e8nes permettant le d\u00e9veloppement des vaccins multivalents.",
            "cite_spans": [
                {
                    "start": 538,
                    "end": 542,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 729,
                    "end": 733,
                    "text": "[14]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 734,
                    "end": 738,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 739,
                    "end": 743,
                    "text": "[16]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 817,
                    "end": 821,
                    "text": "[17]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 822,
                    "end": 826,
                    "text": "[18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 827,
                    "end": 831,
                    "text": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 832,
                    "end": 836,
                    "text": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 837,
                    "end": 841,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 842,
                    "end": 846,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1021,
                    "end": 1024,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1025,
                    "end": 1028,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1029,
                    "end": 1032,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1033,
                    "end": 1036,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1037,
                    "end": 1040,
                    "text": "24]",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "Br\u00e8ve description des diff\u00e9rents vecteurs \u00e0 administration muqueuse"
        },
        {
            "text": "Un des probl\u00e8mes majeurs rencontr\u00e9s en vaccinologie est souvent la faible immunog\u00e9nicit\u00e9 des antig\u00e8nes utilis\u00e9s. L'utilisation d'adjuvants telles que la toxine chol\u00e9rique et l'ent\u00e9rotoxine d'Escherichia coli constitue une bonne solution ; ils sont aujourd'hui consid\u00e9r\u00e9s comme les adjuvants muqueux les plus puissants connus \u00e0 ce jour. Malheureusement, ces adjuvants tr\u00e8s effi caces peuvent causer des diarrh\u00e9es s\u00e9v\u00e8res chez l'homme et induire des r\u00e9ponses de type Th2 ind\u00e9sirables [34, 35] . Par ailleurs, le pouvoir adjuvant de cytokines est en cours d'\u00e9valuation et pourrait constituer une prochaine g\u00e9n\u00e9ration d'adjuvants [36, 37] . Parmi ces cytokines, l'interleukine-12 (IL-12) est une mol\u00e9cule stimulatrice du syst\u00e8me immunitaire dont l'emploi s'est r\u00e9v\u00e9l\u00e9 tr\u00e8s prometteur en co-administration avec un antig\u00e8ne [38] . De plus, l'IL-12 a \u00e9t\u00e9 utilis\u00e9e avec succ\u00e8s dans des immunoth\u00e9rapies contre certains cancers et son utilisation emp\u00eache le d\u00e9veloppement d'un \u00e9tat de tol\u00e9rance contre l'antig\u00e8ne utilis\u00e9. Ce dernier point est tr\u00e8s int\u00e9ressant dans le cadre du d\u00e9veloppement de vaccins vivants car la persistance de l'antig\u00e8ne au niveau des muqueuses peut induire un \u00e9tat de tol\u00e9rance non souhait\u00e9.",
            "cite_spans": [
                {
                    "start": 482,
                    "end": 486,
                    "text": "[34,",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 487,
                    "end": 490,
                    "text": "35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 626,
                    "end": 630,
                    "text": "[36,",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 631,
                    "end": 634,
                    "text": "37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 818,
                    "end": 822,
                    "text": "[38]",
                    "ref_id": "BIBREF37"
                }
            ],
            "ref_spans": [],
            "section": "Adjuvants muqueux"
        },
        {
            "text": "Mycobacterium bovis BCG [25] Listeria monocytogenes [26] Salmonella spp. [27] Vibrio cholera [28] Shigella spp. [29] Bordetella spp.",
            "cite_spans": [
                {
                    "start": 24,
                    "end": 28,
                    "text": "[25]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 52,
                    "end": 56,
                    "text": "[26]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 73,
                    "end": 77,
                    "text": "[27]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 93,
                    "end": 97,
                    "text": "[28]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 112,
                    "end": 116,
                    "text": "[29]",
                    "ref_id": "BIBREF28"
                }
            ],
            "ref_spans": [],
            "section": "Pathog\u00e8nes att\u00e9nu\u00e9s"
        },
        {
            "text": "[30]",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Pathog\u00e8nes att\u00e9nu\u00e9s"
        },
        {
            "text": "Streptococcus gordonii [31] Lactococcus lactis [5] Lactobacillus spp. [32] Staphylococcus spp. [33] ",
            "cite_spans": [
                {
                    "start": 23,
                    "end": 27,
                    "text": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 47,
                    "end": 50,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 70,
                    "end": 74,
                    "text": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 95,
                    "end": 99,
                    "text": "[33]",
                    "ref_id": "BIBREF32"
                }
            ],
            "ref_spans": [],
            "section": "Bact\u00e9ries non pathog\u00e8nes"
        },
        {
            "text": "La n\u00e9cessit\u00e9 toujours actuelle de d\u00e9velopper des vaccins plus s\u00fbrs, faciles \u00e0 administrer et peu on\u00e9reux, a conduit \u00e0 une recherche intense sur l'utilisation potentielle d'organismes vivants recombinants comme vecteurs d'antig\u00e8nes protecteurs, administrables en particulier par voie locale. L'attention s'est donc tourn\u00e9e vers l'utilisation de BL \u00e0 Gram-positif et commensales comme vecteurs d'antig\u00e8nes [5] . Leur totale innocuit\u00e9, alli\u00e9e aux capacit\u00e9s de certaines d'entre elles \u00e0 coloniser les cavit\u00e9s corporelles externes, d\u00e9signe les BL, en particulier les lactobacilles, comme candidats de choix pour d\u00e9livrer des antig\u00e8nes vaccinaux au niveau des muqueuses. Ces bact\u00e9ries pr\u00e9sentent en outre l'avantage d'\u00eatre ais\u00e9ment administrables par voie orale ou locale. L'\u00e9valuation du potentiel des BL en tant que vecteurs vivants de vaccination a \u00e9t\u00e9 initi\u00e9e il y a quelques ann\u00e9es dans diff\u00e9rents laboratoires dans le monde entier [5, 11, 12] . En plus de leur statut GRAS, de nombreux antig\u00e8nes et cytokines ont \u00e9t\u00e9 produits \u00e0 ce jour chez diff\u00e9rentes BL et l'administration mucosale de ces BL g\u00e9n\u00e9tiquement modifi \u00e9es chez la souris stimulent une r\u00e9ponse immunitaire \u00e0 la fois muqueuse et syst\u00e9mique (tableau II). Afi n d'identifi er l'esp\u00e8ce de bact\u00e9rie permettant d'induire une protection \u00e0 long terme, deux types de BL ont \u00e9t\u00e9 \u00e9tudi\u00e9s selon qu'ils persistent (e.g. certaines esp\u00e8ces de lactobacilles) ou non (e.g. Lactococcus lactis) dans le tube digestif. Le mode de production de l'antig\u00e8ne par la bact\u00e9rie recombinante conduisant au meilleur effet a \u00e9t\u00e9 examin\u00e9 \u00e9galement. La production d'un antig\u00e8ne par une BL peut \u00eatre envisag\u00e9e (en th\u00e9orie) dans trois diff\u00e9rentes localisations cellulaires : dans la cellule, \u00e0 sa surface, ou s\u00e9cr\u00e9t\u00e9e [11] . L'expression dans ces trois localisations a pour but une optimisation des interactions prot\u00e9ine-h\u00f4te et chaque localisation pr\u00e9sente des avantages et des inconv\u00e9nients selon l'application. Une forme cytoplasmique permet de prot\u00e9ger la prot\u00e9ine des environnements ext\u00e9rieurs drastiques (tel que les jus gastriques dans l'estomac) mais une lyse cellulaire est n\u00e9cessaire pour d\u00e9livrer la prot\u00e9ine. La forme s\u00e9cr\u00e9t\u00e9e permet une meilleure diffusion de la prot\u00e9ine \u00e0 l'ext\u00e9rieur de la bact\u00e9rie et donc une meilleure accessibilit\u00e9 \u00e0 l'h\u00f4te. Elle est en revanche plus expos\u00e9e \u00e0 la prot\u00e9olyse. La forme ancr\u00e9e de la prot\u00e9ine pourrait constituer un compromis entre les deux formes pr\u00e9c\u00e9dentes. La pr\u00e9sence de la prot\u00e9ine \u00e0 la surface de la bact\u00e9rie permettrait une meilleure accessibilit\u00e9 de l'h\u00f4te pour la prot\u00e9ine tout en limitant les probl\u00e8mes de prot\u00e9olyse de la prot\u00e9ine prot\u00e9g\u00e9e par la paroi de la bact\u00e9rie. Dans ce contexte, plusieurs travaux ont \u00e9t\u00e9 r\u00e9alis\u00e9s pour comparer la production de diff\u00e9rents antig\u00e8nes chez les BL en utilisant ces trois localisations et l'\u00e9valuation de leurs effets immunomodulateurs [39] [40] [41] . Ces \u00e9tudes ont montr\u00e9 que les r\u00e9ponses immunitaires les plus \u00e9lev\u00e9es sont obtenues avec des antig\u00e8nes expos\u00e9s \u00e0 la surface des BL. Ainsi, la plupart des \u00e9tudes r\u00e9centes ont choisi une exposition \u00e0 la surface de l'antig\u00e8ne d'int\u00e9r\u00eat, plut\u00f4t qu'une localisation intra-ou extracellulaire.",
            "cite_spans": [
                {
                    "start": 404,
                    "end": 407,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 931,
                    "end": 934,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 935,
                    "end": 938,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 939,
                    "end": 942,
                    "text": "12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1747,
                    "end": 1751,
                    "text": "[11]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 2863,
                    "end": 2867,
                    "text": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 2868,
                    "end": 2872,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 2873,
                    "end": 2877,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                }
            ],
            "ref_spans": [],
            "section": "Bact\u00e9ries lactiques comme vecteurs \u00e0 administration muqueuse"
        },
        {
            "text": "Lactococcus lactis est une bact\u00e9rie \u00e0 Gram-positif en forme de coque ovo\u00efde. L. lactis est largement utilis\u00e9e dans la fabrication de produits laitiers, en particulier de fromages. De plus, cette bact\u00e9rie acidifi e les milieux dans lesquels elle se d\u00e9veloppe et peut synth\u00e9tiser des bact\u00e9riocines [42] . Cela permet d'\u00e9viter le d\u00e9veloppement de microorganismes ind\u00e9sirables dans les produits laitiers et participe \u00e0 la pr\u00e9servation de la qualit\u00e9 hygi\u00e9nique des produits. L. lactis a \u00e9t\u00e9 largement \u00e9tudi\u00e9e et manipul\u00e9e ces derni\u00e8res ann\u00e9es pour la production de prot\u00e9ines h\u00e9t\u00e9rologues tels que plusieurs antig\u00e8nes d'origine virale ou bact\u00e9rienne, ainsi que des mol\u00e9cules biologiquement actives (cytokines, hormones, etc.) [11, 12] . Notre \u00e9quipe a d\u00e9velopp\u00e9 de nombreux outils d'optimisation de la production de prot\u00e9ines h\u00e9t\u00e9rologues chez cette bact\u00e9rie que nous d\u00e9crivons dans les paragraphes suivants.",
            "cite_spans": [
                {
                    "start": 296,
                    "end": 300,
                    "text": "[42]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 720,
                    "end": 724,
                    "text": "[11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 725,
                    "end": 728,
                    "text": "12]",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": "Lactococcus lactis en tant que vaccin vivant"
        },
        {
            "text": "Aujourd'hui, une large gamme de signaux d'expression constitutive ou inductible a \u00e9t\u00e9 d\u00e9crite chez L. lactis [5, 11, 12] . Gr\u00e2ce \u00e0 ces \u00e9tudes, nous avons constitu\u00e9 toute une gamme de promoteurs naturels constitutifs ou inductibles. Dans le cadre de nos \u00e9tudes, nous avons choisi d'utiliser deux types de promoteurs principalement : i) le promoteur constitutif fort P59 [47] et, ii) le promoteur inductible \u00e0 la nisine (P nisA ) [48] .",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 112,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 113,
                    "end": 116,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 117,
                    "end": 120,
                    "text": "12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 369,
                    "end": 373,
                    "text": "[47]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 428,
                    "end": 432,
                    "text": "[48]",
                    "ref_id": "BIBREF47"
                }
            ],
            "ref_spans": [],
            "section": "Production de prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis"
        },
        {
            "text": "La nisine est une bact\u00e9riocine de L. lactis largement utilis\u00e9e comme substance antimicrobienne en industrie agro-alimentaire. Onze g\u00e8nes chromosomiques adjacents (nisABTCIPRKFEG) codent pour la biosynth\u00e8se et l'immunit\u00e9 contre la nisine [49] . Le g\u00e8ne nisA correspond au g\u00e8ne de structure de la nisine et les g\u00e8nes nisRK constituent le syst\u00e8me \u00e0 deux composantes responsable de l'induction des autres g\u00e8nes du cluster. L'\u00e9tude de la r\u00e9gulation de la biosynth\u00e8se de la nisine a permis de mettre en \u00e9vidence le processus par lequel la nisine extracellulaire se fi xe sur la prot\u00e9ine NisK qui s'autophosphoryle et devient capable d'activer le r\u00e9gulateur NisR par phosphorylation. NisR active ensuite la transcription des op\u00e9rons nisABTCIP et nisFEG. La caract\u00e9risation de la r\u00e9gulation de ce syst\u00e8me a permis de mettre au point un syst\u00e8me d'expression inductible chez L. lactis utilisant le promoteur du g\u00e8ne nisA et les g\u00e8nes nisRK [50] . Le g\u00e8ne d'int\u00e9r\u00eat est clon\u00e9 en aval du promoteur P nisA et le plasmide est introduit dans une souche poss\u00e9dant les g\u00e8nes nisRK (ie. L. lactis NZ9000). L'addition de quantit\u00e9s sub-inhibitrices de nisine dans le milieu de culture d\u00e9clenche l'expression du g\u00e8ne d'int\u00e9r\u00eat proportionnellement \u00e0 la quantit\u00e9 de nisine pr\u00e9sente. Ce syst\u00e8me est aujourd'hui largement utilis\u00e9 pour exprimer des prot\u00e9ines h\u00e9t\u00e9rologues chez les BL en g\u00e9n\u00e9ral [50] .",
            "cite_spans": [
                {
                    "start": 237,
                    "end": 241,
                    "text": "[49]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 930,
                    "end": 934,
                    "text": "[50]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1369,
                    "end": 1373,
                    "text": "[50]",
                    "ref_id": "BIBREF49"
                }
            ],
            "ref_spans": [],
            "section": "Le syst\u00e8me NICE (nisin induced controlled expression)"
        },
        {
            "text": "Dans notre laboratoire, nous avons d\u00e9velopp\u00e9 un syst\u00e8me de production-exportation de prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis \u00e0 l'aide d'une prot\u00e9ine s\u00e9cr\u00e9t\u00e9e mod\u00e8le tr\u00e8s stable et bien caract\u00e9ris\u00e9e, la nucl\u00e9ase de Staphylococcus aureus (Nuc) [51] . Nuc est consid\u00e9r\u00e9e comme un bon rapporteur car son activit\u00e9 est tr\u00e8s facilement d\u00e9tectable in vivo par un test de coloration sur des colonies bact\u00e9riennes, en culture liquide ou extraites du tractus digestif. Ce syst\u00e8me est compos\u00e9 d'une famille de vecteurs qui permettent le ciblage contr\u00f4l\u00e9 de l'expression d'une prot\u00e9ine \u00e0 l'int\u00e9rieur de la cellule, ancr\u00e9e \u00e0 la paroi ou s\u00e9cr\u00e9t\u00e9e dans le milieu ext\u00e9rieur, pCYT, pSEC et pCWA, respectivement. pCYT : Pour obtenir l'expression d'une prot\u00e9ine dans le cytoplasme, le g\u00e8ne d'int\u00e9r\u00eat est fusionn\u00e9 uniquement au promoteur P nisA . pSEC : La voie de s\u00e9cr\u00e9tion utilis\u00e9e dans nos travaux est la voie Sec-d\u00e9pendante. Elle reconna\u00eet des prot\u00e9ines synth\u00e9tis\u00e9es avec un peptide signal (PS) N-terminal et assure leur exportation et leur translocation. La nature du PS utilis\u00e9 pour s\u00e9cr\u00e9ter une prot\u00e9ine peut beaucoup infl uencer l'effi cacit\u00e9 de s\u00e9cr\u00e9tion de la prot\u00e9ine. Un des PS les plus effi caces pour s\u00e9cr\u00e9ter prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis est celui de la prot\u00e9ine Usp45 qui est la prot\u00e9ine majoritaire s\u00e9cr\u00e9t\u00e9e par L. lactis [52] . Ainsi, le PS de cette prot\u00e9ine a \u00e9t\u00e9 utilis\u00e9 pour exporter de nombreuses prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis [53] .",
            "cite_spans": [
                {
                    "start": 240,
                    "end": 244,
                    "text": "[51]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 1325,
                    "end": 1329,
                    "text": "[52]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 1443,
                    "end": 1447,
                    "text": "[53]",
                    "ref_id": "BIBREF52"
                }
            ],
            "ref_spans": [],
            "section": "Les vecteurs d'expression"
        },
        {
            "text": "pCWA : Pour obtenir une prot\u00e9ine ancr\u00e9e \u00e0 la paroi de la bact\u00e9rie, le g\u00e8ne d'int\u00e9r\u00eat est fusionn\u00e9 au PS Usp45 et au domaine d'ancrage de la prot\u00e9ine M6 de Streptococcus pyogenes (CWA M6 ). Ce domaine contient les signaux n\u00e9cessaires pour un ancrage \u00e0 la paroi [54] . Ces vecteurs, fonctionnels dans un large spectre de BL, sont utilis\u00e9s en routine au sein de notre laboratoire pour la production d'une 40 aine de prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis (tableau II). Plus r\u00e9cemment, nous avons d\u00e9velopp\u00e9 diff\u00e9rents syst\u00e8mes d'expression bas\u00e9s sur des promoteurs inductibles aux sels biliaires qui constituent une bonne alternative au promoteur inductible \u00e0 la nisine.",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 264,
                    "text": "[54]",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [],
            "section": "Les vecteurs d'expression"
        },
        {
            "text": "Nous avons aussi travaill\u00e9 sur d'autres vecteurs d'expression et les facteurs de l'h\u00f4te affectant la production-s\u00e9cr\u00e9tion chez L. lactis. Nous avons ainsi d\u00e9velopp\u00e9 un vecteur (pSEC:LEISS) contenant un propeptide synth\u00e9tique (LEISSTCDA), identifi\u00e9 comme \u00ab booster \u00bb de la production et de la s\u00e9cr\u00e9tion [105] . Pour les facteurs de l'h\u00f4te affectant la production-s\u00e9cr\u00e9tion, nous avons identifi \u00e9 le g\u00e8ne ybdD. L'inactivation de ce g\u00e8ne entra\u00eene une surproduction des seules prot\u00e9ines s\u00e9cr\u00e9t\u00e9es selon un m\u00e9canisme non encore \u00e9lucid\u00e9 [Morello et al., soumis]. Nous avons aussi compl\u00e9ment\u00e9 la machinerie de s\u00e9cr\u00e9tion de L. lactis avec SecDF de B. subtilis et avons observ\u00e9 une am\u00e9lioration des niveaux de production et de s\u00e9cr\u00e9tion dans la souche r\u00e9sultante [106] . Enfi n, nous avons obtenu r\u00e9cemment une souche de L. lactis qui ne produit ni l'unique prot\u00e9ase extracellulaire HtrA [107] , ni la principale prot\u00e9ase intracellulaire ClpP [108] . Cette souche permet une production contr\u00f4l\u00e9e et stable de diff\u00e9rentes prot\u00e9ines h\u00e9t\u00e9rologues qui \u00e9taient hautement d\u00e9grad\u00e9es dans la souche sauvage [109] .",
            "cite_spans": [
                {
                    "start": 302,
                    "end": 307,
                    "text": "[105]",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 754,
                    "end": 759,
                    "text": "[106]",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 879,
                    "end": 884,
                    "text": "[107]",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 934,
                    "end": 939,
                    "text": "[108]",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 1090,
                    "end": 1095,
                    "text": "[109]",
                    "ref_id": "BIBREF108"
                }
            ],
            "ref_spans": [],
            "section": "Am\u00e9lioration de la production-s\u00e9cr\u00e9tion de prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis"
        },
        {
            "text": "Aujourd'hui, des nombreuses \u00e9tudes justifi ent l'utilisation des souches recombinantes de L. lactis pour induire une r\u00e9ponse immunitaire \u00e0 la fois muqueuse et syst\u00e9mique [11, 12] . La premi\u00e8re tentative pour \u00e9valuer le potentiel de L. lactis en tant que vaccin \u00e0 administration muqueuse a \u00e9t\u00e9 r\u00e9alis\u00e9e avec une souche recombinante de lactocoque produisant une forme ancr\u00e9e de l'antig\u00e8ne protecteur (PAc) de Streptococcus mutans [69] . Les souris immunis\u00e9es par voie orale avec cette souche recombinante d\u00e9veloppaient des anticorps IgG s\u00e9riques et IgA mucosales sp\u00e9cifi ques du PAc. Ces r\u00e9sultats montrent pour la premi\u00e8re fois que L. lactis peut \u00eatre utilis\u00e9e comme un vecteur pour d\u00e9livrer un antig\u00e8ne au syst\u00e8me immunitaire. Toutefois, Wells et al. [59] rapportent pour la premi\u00e8re fois l'utilisation d'une souche recombinante de L. lactis vivante produisant le fragment C de la toxine t\u00e9tanique (TTFC) comme antig\u00e8ne mod\u00e8le, pour prot\u00e9ger des souris contre un challenge l\u00e9tal avec la toxine t\u00e9tanique apr\u00e8s administration sous-cutan\u00e9e de la souche recombinante. Plus tard, le m\u00eame groupe \u00e9value l'effet de l'administration par voie orale ou nasale de souches recombinantes de lactocoques produisant la TTFC chez la souris [110, 111] . L'immunisation orale chez la souris avec ces lactocoques recombinants entra\u00eene une r\u00e9ponse humorale (ie. anticorps IgG s\u00e9riques et IgA mucosales sp\u00e9cifi ques du TTFC) moins importante que l'administration intranasale, mais l'effi cacit\u00e9 protectrice mesur\u00e9e (c'est-\u00e0-dire le d\u00e9fi avec la toxine t\u00e9tanique) \u00e9tait la m\u00eame. Plusieurs \u00e9tudes ont \u00e9t\u00e9 men\u00e9es apr\u00e8s ces travaux pour analyser l'expression de nombreuses prot\u00e9ines h\u00e9t\u00e9rologues d'origine virale, bact\u00e9rienne ou eucaryote chez L. lactis [11 et tableau II]. L'immunog\u00e9nicit\u00e9 des souches recombinantes r\u00e9sultantes a \u00e9t\u00e9 \u00e9valu\u00e9e dans certains cas dans des mod\u00e8les animaux avec des r\u00e9sultats tr\u00e8s prometteurs. En particulier, notre \u00e9quipe a r\u00e9ussi (comme cit\u00e9 ci-dessus) \u00e0 produire une 40 aine de prot\u00e9ines h\u00e9t\u00e9rologues chez L. lactis (tableau II). Notre objectif \u00e9tant d'induire une r\u00e9ponse immune au niveau des muqueuses de l'h\u00f4te, nos efforts se sont concentr\u00e9s sur la pr\u00e9sentation de prot\u00e9ines d'int\u00e9r\u00eat m\u00e9dical telles que des cytokines, des antig\u00e8nes, des allerg\u00e8nes et des antioxydants par des BL. Dans cette partie du chapitre, nous d\u00e9crivons les trois projets les plus marquants de notre \u00e9quipe qui concernent la production de prot\u00e9ines d'int\u00e9r\u00eat sant\u00e9 par L. lactis et comportant tous une phase de construction de souches suivie d'une phase d'exp\u00e9rimentations chez l'animal : i) construction de souches vaccinales de L. lactis afi n de prot\u00e9ger et de lutter contre le papillomavirus humain de type 16 (HPV-16), ii) pr\u00e9vention et traitement des allergies \u00e0 la -lactoglobuline (BLG) avec de lactocoques recombinants produisant la BLG et l'interleukine-12 (IL-12) ; et iii) utilisation des lactocoques recombinants producteurs de leptine humaine en vue du traitement de l'ob\u00e9sit\u00e9.",
            "cite_spans": [
                {
                    "start": 170,
                    "end": 174,
                    "text": "[11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 175,
                    "end": 178,
                    "text": "12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 428,
                    "end": 432,
                    "text": "[69]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 751,
                    "end": 755,
                    "text": "[59]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1225,
                    "end": 1230,
                    "text": "[110,",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 1231,
                    "end": 1235,
                    "text": "111]",
                    "ref_id": "BIBREF110"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9ponse immune contre des antig\u00e8nes produits par Lactococcus lactis"
        },
        {
            "text": "Le papillomavirus humain de type 16 (HPV-16) est un des virus \u00e0 potentiel oncog\u00e8ne que l'on retrouve (avec le type 18) dans plus de 90 % des cancers du col de l'ut\u00e9rus (300 000 d\u00e9c\u00e8s par an dans le monde) [112] . Les strat\u00e9gies actuelles pour pr\u00e9venir ou traiter l'infection par ce virus sont prometteuses mais co\u00fbteuses. Des vaccins prophylactiques bas\u00e9s sur des VLPs (virus-like particles) ont r\u00e9cemment induit des baisses signifi catives des infections \u00e0 l'HPV-16 et 18 et des cancers associ\u00e9s \u00e0 ces infections en essais cliniques humains [113] . Cependant, ces vaccins agissent seulement au niveau de l'infection et n'ont aucun effet th\u00e9rapeutique. Par ailleurs, leur co\u00fbt encore tr\u00e8s \u00e9lev\u00e9 limite leur utilisation dans les pays en voie de d\u00e9veloppement o\u00f9 l'on d\u00e9nombre environ 80 % de d\u00e9c\u00e8s li\u00e9s au cancer associ\u00e9s \u00e0 l'HPV. Dans ce projet, nous avons utilis\u00e9 L. lactis pour d\u00e9livrer deux prot\u00e9ines: i) l'antig\u00e8ne E7 du HPV-16, prot\u00e9ine retrouv\u00e9e syst\u00e9matiquement dans des carcinomes provoqu\u00e9s par des infections par des HPV et un des antig\u00e8nes candidats pour le d\u00e9veloppement d'une th\u00e9rapie anti-HPV et ii) l'interleukine-12 (IL-12), une mol\u00e9cule stimulatrice de la r\u00e9ponse immunitaire cellulaire lors d'infections [38] . Dans un premier temps, nous avons construit une souche g\u00e9n\u00e9tiquement modifi \u00e9e de L. lactis s\u00e9cr\u00e9tant de fa\u00e7on stable l'antig\u00e8ne E7, alors qu'E7 est d\u00e9crite comme une prot\u00e9ine tr\u00e8s labile [79] . Puis, gr\u00e2ce aux outils d\u00e9velopp\u00e9s pr\u00e9c\u00e9demment, nous avons cibl\u00e9 l'expression d'E7 dans trois localisations diff\u00e9rentes (ie. cytoplasme, paroi et milieu extracellulaire) et nous avons pu mettre en \u00e9vidence une r\u00e9ponse immune sp\u00e9cifi que d'E7 chez la souris, suite \u00e0 l'administration nasale avec les trois souches recombinantes exprimant E7. Nous avons \u00e9galement observ\u00e9 une immunog\u00e9nicit\u00e9 accrue de la forme ancr\u00e9e d'E7 [41] . Nous avons ensuite construit une souche recombinante de L. lactis s\u00e9cr\u00e9tant l'IL-12. Cette cytokine d\u00e9j\u00e0 utilis\u00e9e avec succ\u00e8s en immunoth\u00e9rapie et canc\u00e9rologie n'avait jusqu'alors jamais \u00e9t\u00e9 produite chez une bact\u00e9rie \u00e0 Gram positif. En effet, une des diffi cult\u00e9s concernant la production d'IL-12 est qu'elle requiert l'assemblage de deux sous-unit\u00e9s (p35 et p40) par un pont disulfure. Pour cela, nous avons d\u00e9velopp\u00e9 des souches de L. lactis permettant la production de : i) de p35 et p40, donnant une forme h\u00e9t\u00e9rodim\u00e9rique native de l'IL-12 et ii) d'une prot\u00e9ine de fusion des deux sous-unit\u00e9s de l'IL-12 (scIL-12). L'activit\u00e9 biologique de l'IL-12 produite par L. lactis a \u00e9t\u00e9 ensuite confi rm\u00e9e in vitro sur des cellules de rate de souris puis in vivo par administration intranasale \u00e0 des souris [98] . Nous avons \u00e9galement mesur\u00e9 le potentiel adjuvant de ces souches recombinantes de lactocoques en les associant \u00e0 la souche de L. lactis produisant la forme ancr\u00e9e de l'antig\u00e8ne E7 [98] . Enfi n, afi n d'\u00e9valuer les capacit\u00e9s pr\u00e9ventives et curatives de la combinaison de ces deux lactocoques, nous avons mis en place un mod\u00e8le murin dans lequel nous induisions des tumeurs par implantation sous-cutan\u00e9e de cellules tumorales exprimant l'antig\u00e8ne E7 de l'HPV-16 (TC-1), et dont nous mesurions l'\u00e9volution suite \u00e0 l'administration intranasale de souches [114] . Nous avons \u00e9valu\u00e9 les effets pr\u00e9ventifs et curatifs de la co-administration intranasale chez la souris de souches de lactocoques produisant E7 et IL-12 sur le d\u00e9veloppement de la tumeur TC-1. Nos r\u00e9sultats d\u00e9montrent que l'administration pr\u00e9ventive de lactocoques avant l'injection des cellules tumorales induit l'absence de d\u00e9veloppement de tumeurs chez 50 % des animaux immunis\u00e9s. Nous avons ainsi constat\u00e9 un effet adjuvant signifi catif de l'IL-12 co-d\u00e9livr\u00e9e avec l'antig\u00e8ne E7 dans la mesure o\u00f9 en l'absence de la souche produisant l'IL-12, nous observons l'absence de tumeurs dans seulement 25 % des souris immunis\u00e9es. De plus, les souris immunis\u00e9es avec LL-E7 et LL-IL12 sont capables de r\u00e9sister \u00e0 un second d\u00e9fi (2 mois apr\u00e8s la premi\u00e8re immunisation) sugg\u00e9rant que l'immunit\u00e9 induite est durable [114] . L'utilisation th\u00e9rapeutique de ces souches chez des souris o\u00f9 les tumeurs sont d\u00e9j\u00e0 implant\u00e9es, provoque la r\u00e9gression totale des tumeurs chez 35 % des animaux trait\u00e9s. Ces effets anti-tumoraux sont la cons\u00e9quence d'une r\u00e9ponse cytotoxique d\u00e9pendante des lymphocytes T CD4+ et CD8+. Ces r\u00e9sultats chez la souris constituent la premi\u00e8re mise en \u00e9vidence d'un effet pr\u00e9ventif et curatif contre le cancer du col de l'ut\u00e9rus par vaccination muqueuse avec des souches recombinantes de lactocoques. Le vaccin, disponible actuellement en France, a un co\u00fbt tr\u00e8s \u00e9lev\u00e9 (pr\u00e8s de 150 \u20ac la dose \u00e0 raison de trois doses par personne vaccin\u00e9e), ce qui limite son utilisation dans les pays en voie de d\u00e9veloppement. Il faut cependant souligner que ces strat\u00e9gies bas\u00e9es sur des bact\u00e9ries transg\u00e9niques demeurent aujourd'hui des mod\u00e8les d'\u00e9tude non encore autoris\u00e9s chez l'Homme. Ces derniers temps, on peut cependant noter une \u00e9volution sensible concr\u00e9tis\u00e9e entre autres par les premiers essais cliniques de Phase I men\u00e9s chez l'Homme avec des souches de lactocoques s\u00e9cr\u00e9trices d'IL-10 [115] .",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 210,
                    "text": "[112]",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 542,
                    "end": 547,
                    "text": "[113]",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 1221,
                    "end": 1225,
                    "text": "[38]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 1416,
                    "end": 1420,
                    "text": "[79]",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 1843,
                    "end": 1847,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 2652,
                    "end": 2656,
                    "text": "[98]",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 2839,
                    "end": 2843,
                    "text": "[98]",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 3211,
                    "end": 3216,
                    "text": "[114]",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 4026,
                    "end": 4031,
                    "text": "[114]",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 5106,
                    "end": 5111,
                    "text": "[115]",
                    "ref_id": "BIBREF114"
                }
            ],
            "ref_spans": [],
            "section": "Construction de souches vaccinales de BL afi n de prot\u00e9ger et de lutter contre l'HPV-16"
        },
        {
            "text": "La pr\u00e9valence des allergies alimentaires a particuli\u00e8rement augment\u00e9 au cours des 20 derni\u00e8res ann\u00e9es [116] . Les r\u00e9actions et manifestations allergiques r\u00e9sultent de l'induction, chez des sujets g\u00e9n\u00e9tiquement pr\u00e9dispos\u00e9s, de lymphocytes T auxiliaires (ou Th pour T \u00ab helper \u00bb) de type 2 (Th2) contre certaines prot\u00e9ines alimentaires inoffensives normalement tol\u00e9r\u00e9es par l'organisme: ces prot\u00e9ines deviennent des allerg\u00e8nes. Il existe dans l'organisme une r\u00e9gulation fi ne entre les diff\u00e9rentes sous-populations lymphocytaires Th1, Th2 et Th17. Cette r\u00e9gulation r\u00e9sulte d'actions inhibitrices de ces diff\u00e9rentes populations les unes envers les autres, et/ou du fait de l'activation de cellules r\u00e9gulatrices (Treg). Les lymphocytes Th1 sont s\u00e9cr\u00e9teurs des cytokines pro-infl ammatoires, tels que l'IL-12 et l'interf\u00e9ron gamma (IFN-), qui favorisent l'induction d'une immunit\u00e9 \u00e0 m\u00e9diation cellulaire et la production d'IgG2a chez la souris (IgG1 chez l'homme) [117] . L'IL-12 inhibe le d\u00e9veloppement des lymphocytes Th2. Les lymphocytes Th2 sont quant \u00e0 eux s\u00e9cr\u00e9teurs de cytokines anti-inflammatoires qui conduisent \u00e0 la production d'IgE sp\u00e9cifi ques et inhibent le d\u00e9veloppement des cellules Th1 (IL-4, IL-13). L'induction mod\u00e9r\u00e9e de cellules sp\u00e9cifi ques de type Th1 pourrait donc permettre la modulation des cellules Th2 sp\u00e9cifi ques d'allerg\u00e8nes, responsables de la sensibilisation allergique (production d'IgE sp\u00e9cifi ques d'un allerg\u00e8ne) et de la r\u00e9action allergique (apparition de sympt\u00f4mes suite \u00e0 un test de provocation). Plusieurs \u00e9tudes sugg\u00e8rent que certaines bact\u00e9ries probiotiques, dont certaines BL, pourraient agir favorablement et participer au maintien de cet \u00e9quilibre Th1/Th2. Elles repr\u00e9sentent donc des bonnes candidates pour r\u00e9guler les maladies allergiques. Gr\u00e2ce \u00e0 un mod\u00e8le murin d'allergie alimentaire \u00e0 la beta-lactoglobuline bovine (BLG) [118] , un des allerg\u00e8nes majeurs du lait de vache, nous avons pu \u00e9tudier l'effet de la co-administration par voie orale ou intranasale de lactocoques recombinants produisant la BLG et l'IL-12 sur la sensibilisation allergique. Gr\u00e2ce au suivi de la r\u00e9ponse immunitaire sp\u00e9cifi que induite chez ces souris (dosage des anticorps sp\u00e9cifi ques et des cytokines Th1/Th2), nous avons d\u00e9montr\u00e9 que l'administration intranasale de lactocoques recombinants stimule de fa\u00e7on signifi cative une r\u00e9ponse immunitaire Th1 par rapport aux souris contr\u00f4les. Ce pr\u00e9-traitement permet de pr\u00e9venir la sensibilisation allergique \u00e0 la BLG (c'est\u00e0-dire la production d'IgE sp\u00e9cifi ques et de cytokines Th2) et le d\u00e9clenchement de la r\u00e9action allergique chez les souris (\u00e9osinophilie locale) [119] . De plus, nous avons montr\u00e9 l'effet positif de l'administration th\u00e9rapeutique des lactocoques produisant la BLG sur certains marqueurs de l'allergie au lait de vache [120] . Enfi n, nous avons mis en \u00e9vidence que l'administration nasale de la souche s\u00e9cr\u00e9tant l'IL-12 diminue aussi les manifestations allergiques dans un mod\u00e8le d'asthme induit par l'ovalbumine [121] . 7.3. Utilisation de souches recombinantes de L. lactis productrices de la leptine humaine en vue du traitement de l'ob\u00e9sit\u00e9 L'ob\u00e9sit\u00e9 constitue un probl\u00e8me mondial de sant\u00e9 publique et les traitements susceptibles de r\u00e9duire ce probl\u00e8me ont un tr\u00e8s fort potentiel th\u00e9rapeutique. Nous avons d\u00e9velopp\u00e9 des lactocoques recombinants producteurs de la leptine humaine, hormone produite principalement par l'adipocyte, qui informe le cerveau de l'\u00e9tat des r\u00e9serves adipeuses. Chez la souris ob\u00e8se (ob/ob), la d\u00e9fi cience en leptine conduit \u00e0 une ob\u00e9sit\u00e9 massive. Nos travaux ont eu pour objet de mesurer les effets de l'administration nasale d'une souche de L. lactis s\u00e9cr\u00e9tant la leptine humaine chez des souris ob/ob. Dans un premier temps, nous avons construit une souche de L. lactis s\u00e9cr\u00e9tant effi cacement la leptine humaine biologiquement active. Nous avons ensuite d\u00e9termin\u00e9 si l'administration intra-nasale de LL-Lep pouvait inhiber la prise alimentaire et la prise de poids des souris ob/ob. Nous avons ainsi observ\u00e9 que l'administration quotidienne de cette souche recombinante de L. lactis \u00e0 ces souris ob\u00e8ses r\u00e9duisait de fa\u00e7on signifi cative le gain de poids et la prise alimentaire [104] . Ces r\u00e9sultats d\u00e9montrent que la leptine (une hormone) est produite sous forme active par L. lactis et que cette souche peut \u00eatre utilis\u00e9e avec succ\u00e8s pour r\u00e9guler le poids corporel et la consommation des aliments. L'ensemble de ces r\u00e9sultats confi rme tout le potentiel des lactocoques recombinants en tant que vecteur de prot\u00e9ines d'int\u00e9r\u00eat sant\u00e9 et laissent esp\u00e9rer que de telles souches de BL recombinantes seront un jour autoris\u00e9es afi n d'apporter de nouvelles solutions dans le futur pour la pr\u00e9vention et le traitement de maladies.",
            "cite_spans": [
                {
                    "start": 102,
                    "end": 107,
                    "text": "[116]",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 959,
                    "end": 964,
                    "text": "[117]",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 1867,
                    "end": 1872,
                    "text": "[118]",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 2636,
                    "end": 2641,
                    "text": "[119]",
                    "ref_id": "BIBREF118"
                },
                {
                    "start": 2809,
                    "end": 2814,
                    "text": "[120]",
                    "ref_id": "BIBREF119"
                },
                {
                    "start": 3004,
                    "end": 3009,
                    "text": "[121]",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 4203,
                    "end": 4208,
                    "text": "[104]",
                    "ref_id": "BIBREF103"
                }
            ],
            "ref_spans": [],
            "section": "Pr\u00e9vention et traitement des allergies \u00e0 la BLG avec de lactocoques recombinants produisant la BLG et l'IL-12"
        },
        {
            "text": "Contrairement \u00e0 L. lactis, certaines esp\u00e8ces de lactobacilles peuvent coloniser certaines r\u00e9gions de la muqueuse et induire une r\u00e9ponse immunitaire locale, avantage lors de d\u00e9veloppement d'un vaccin. Par ailleurs, l'utilisation possible de certaines souches probiotiques de lactobacilles comme vecteur \u00e0 administration muqueuse constitue un avantage suppl\u00e9mentaire [32] . Cependant, la biodiversit\u00e9 de ce genre rend leur l'utilisation en tant que vaccin vivant beaucoup plus complexe que celle de L. lactis o\u00f9 une seule souche (MG1363) a \u00e9t\u00e9 utilis\u00e9e. En effet, ce genre est tr\u00e8s r\u00e9pandu et contient plus de 60 esp\u00e8ces qui diff\u00e8rent au niveau de leurs propri\u00e9t\u00e9s biochimiques, \u00e9cologiques et immunologiques. Toutefois, la capacit\u00e9 du genre Lactobacillus \u00e0 produire des antig\u00e8nes a \u00e9galement \u00e9t\u00e9 d\u00e9montr\u00e9e.",
            "cite_spans": [
                {
                    "start": 365,
                    "end": 369,
                    "text": "[32]",
                    "ref_id": "BIBREF31"
                }
            ],
            "ref_spans": [],
            "section": "Lactobacilles en tant que vaccin vivant"
        },
        {
            "text": "Comme pour L. lactis, plusieurs travaux ont rapport\u00e9 l'expression d'une vari\u00e9t\u00e9 de prot\u00e9ines h\u00e9t\u00e9rologues d'origine virale, bact\u00e9rienne ou eucaryote chez les lactobacilles (tableau II). L'utilisation de lactobacilles g\u00e9n\u00e9tiquement modifi \u00e9s pour produire des prot\u00e9ines h\u00e9t\u00e9rologues et pour d\u00e9velopper une nouvelle g\u00e9n\u00e9ration de vaccins muqueux a \u00e9t\u00e9 propos\u00e9e pour la premi\u00e8re fois au d\u00e9but des ann\u00e9es 90 [122, 123] mais la plupart de nos connaissances actuelles sur leur utilisation en tant que vaccin vivant a \u00e9t\u00e9 obtenue avec l'antig\u00e8ne mod\u00e8le TTFC [59, 111] . \u00c0 la fi n des ann\u00e9es 90 et au d\u00e9but des ann\u00e9es 2000, plusieurs laboratoires utilisaient des souches recombinantes de Lb. casei et Lb. plantarum en tant que vecteur pour d\u00e9livrer des prot\u00e9ines d'int\u00e9r\u00eat m\u00e9dical \u00e0 la surface des muqueuses et ils ont observ\u00e9 une forte stimulation de la r\u00e9ponse immunitaire [5, 32] . Ainsi, notre \u00e9quipe a transf\u00e9r\u00e9 tout son savoir-faire sur la production de prot\u00e9ines h\u00e9t\u00e9rologues acquis chez L. lactis dans des souches de lactobacilles (plus sp\u00e9cifi quement dans des souches de Lb. casei et Lb. plantarum) qui pr\u00e9sentent le double int\u00e9r\u00eat de transiter plus lentement dans le tractus digestif et de poss\u00e9der des propri\u00e9t\u00e9s adjuvantes int\u00e9ressantes dans le cas de souches vaccinales. Dans un premier temps, nous avons l'immunog\u00e9nicit\u00e9 d'une souche recombinante de Lb. plantarum produisant l'antig\u00e8ne E7 du HPV-16 a \u00e9t\u00e9 \u00e9valu\u00e9e dans des mod\u00e8les animaux avec des r\u00e9sultats tr\u00e8s prometteurs [81] . Nous avons aussi d\u00e9velopp\u00e9 des souches recombinantes de Lb. casei productrices d'enzymes antioxydantes telles que des catalases ou des superoxyde dismutases. Le but de ce projet portait sur l'\u00e9valuation des effets b\u00e9n\u00e9fi ques de l'administration orale de souches de lactobacilles aux propri\u00e9t\u00e9s anti-oxydantes dans un mod\u00e8le murin d'infl ammation reproduisant des syndromes de type maladies infl ammatoires chroniques de l'intestin (MICI). Les MICI sont des maladies caus\u00e9es par une infl ammation anormale du TD qui provoque des dysfonctionnements gastro-intestinaux. Ces maladies, souvent invalidantes et de longue dur\u00e9e, se caract\u00e9risent par un exc\u00e8s de d\u00e9riv\u00e9s actifs oxyg\u00e9n\u00e9s qui s'accompagne d'une diminution des capacit\u00e9s des syst\u00e8mes antioxydants ainsi que d'un d\u00e9s\u00e9quilibre entre les cytokines pro-et antiinfl ammatoires. Nous avons d'abord exprim\u00e9 chez Lb. casei BL23 une catalase mangan\u00e8se-d\u00e9pendante (MnKaT) de Lb. plantarum [124] et nous avons d\u00e9montr\u00e9 par la suite que l'administration quotidienne orale des souches de Lb. casei produisant ou non la catalase MnKat, chez des souris o\u00f9 une colite a \u00e9t\u00e9 induite par l'ingestion de DSS (dextran sulfate sodium) dans l'eau de boisson, permettait de limiter signifi cativement l'infl ammation au niveau du caecum et du c\u00f4lon, contrairement aux souris t\u00e9moins trait\u00e9es avec du PBS pour lesquelles diarrh\u00e9e et l\u00e9sions mucosales ont \u00e9t\u00e9 observ\u00e9es [125] . Plus r\u00e9cemment, nous avons cherch\u00e9 \u00e0 am\u00e9liorer le potentiel antioxydant de nos souches de lactobacilles en exprimant la SOD (superoxyde dismutase) \u00e0 Mn de L. lactis [Watterlot et al., soumis]. Dans une autre \u00e9tude, Chang et al. [126] ont construit une souche recombinante de Lb. jensenii, une bact\u00e9rie commensale du vagin, pour exprimer et s\u00e9cr\u00e9ter un domaine de la prot\u00e9ine de liaison \u00e0 la prot\u00e9ine gp120 du virus de l'immunod\u00e9fi cience humaine (VIH), CD4, et ils ont d\u00e9montr\u00e9 que la co-incubation de cette bact\u00e9rie recombinante avec un virus VIH portant le g\u00e8ne rapporteur luciferase (i.e. VIH-1HxB2) entra\u00eene une diminution signifi cative de l'entr\u00e9e de ce virus dans des cellules HeLa (exprimant le r\u00e9cepteur CD4-CXCR4-CCR5) in vitro. En plus de leur application en tant que vaccin, les lactobacilles peuvent aussi \u00eatre utilis\u00e9s pour d\u00e9livrer de mol\u00e9cules anti-infectieuses ou produits antimicrobiens in situ. Un exemple est l'utilisation de souches recombinantes de lactobacilles pour pr\u00e9venir la carie dentaire dans un mod\u00e8le animal [127] .",
            "cite_spans": [
                {
                    "start": 404,
                    "end": 409,
                    "text": "[122,",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 410,
                    "end": 414,
                    "text": "123]",
                    "ref_id": "BIBREF122"
                },
                {
                    "start": 551,
                    "end": 555,
                    "text": "[59,",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 556,
                    "end": 560,
                    "text": "111]",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 867,
                    "end": 870,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 871,
                    "end": 874,
                    "text": "32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1481,
                    "end": 1485,
                    "text": "[81]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 2424,
                    "end": 2429,
                    "text": "[124]",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 2890,
                    "end": 2895,
                    "text": "[125]",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 3126,
                    "end": 3131,
                    "text": "[126]",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 3937,
                    "end": 3942,
                    "text": "[127]",
                    "ref_id": "BIBREF126"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9ponse immune contre antig\u00e8nes produits par Lactobacilles spp."
        },
        {
            "text": "Dans les cinq derni\u00e8res ann\u00e9es, l'int\u00e9r\u00eat de l'utilisation de bact\u00e9ries lactiques pour d\u00e9livrer des mol\u00e9cules d'int\u00e9r\u00eat a consid\u00e9rablement augment\u00e9, ce qui s'est traduit par des avanc\u00e9es signifi catives rassembl\u00e9es au sein de cette revue. En d\u00e9pit de ces progr\u00e8s, beaucoup de questions restent en suspens notamment au niveau de la r\u00e9ponse immune g\u00e9n\u00e9r\u00e9e chez l'h\u00f4te par les antig\u00e8nes natifs de la BL utilis\u00e9e comme vecteur ou encore le mode d'administration orale ou intranasale. Actuellement, ce dernier para\u00eet le plus adapt\u00e9 pour induire une bonne r\u00e9ponse immune aux niveaux syst\u00e9mique et mucosal mais il reste \u00e0 s'assurer de l'aspect sanitaire de ces administrations. Les applications th\u00e9rapeutiques ont \u00e9volu\u00e9 de telle mani\u00e8re que l'on peut raisonnablement envisager l'utilisation de BL recombinantes en pr\u00e9vision et lors du traitement de pathologies humaines dans les prochaines ann\u00e9es. Des syst\u00e8mes de confi nement biologique ont \u00e9t\u00e9 mis au point afi n d'emp\u00eacher la diss\u00e9mination de ces BL recombinantes [97] . Cette strat\u00e9gie a permis la mise en place d'un premier essai clinique de phase I [115] qui est une \u00e9tape essentielle dans des utilisations futures de ces outils tr\u00e8s prometteurs.",
            "cite_spans": [
                {
                    "start": 1011,
                    "end": 1015,
                    "text": "[97]",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 1099,
                    "end": 1104,
                    "text": "[115]",
                    "ref_id": "BIBREF114"
                }
            ],
            "ref_spans": [],
            "section": "Conclusions et perspectives"
        },
        {
            "text": "Confl it d'int\u00e9r\u00eat : aucun.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusions et perspectives"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Molecular taxonomy and phylogenetic position of lactic acid bacteria",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Stackebrandt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Teuber",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Biochimie",
            "volume": "70",
            "issn": "3",
            "pages": "317--341",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Response of lactic acid bacteria to the digestive environment",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Mater",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Corthier",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Clin Gastroenterol",
            "volume": "38",
            "issn": "6",
            "pages": "64--70",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Health and nutritional benefi ts from lactic acid bacteria",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Gilliland",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "FEMS Microbiol Rev",
            "volume": "7",
            "issn": "1-2",
            "pages": "175--88",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Lactic acid bacteria as probiotics",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ljungh",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wadstr\u00f6m",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Curr Issues Intest Microbiol",
            "volume": "7",
            "issn": "2",
            "pages": "73--89",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wells",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mercenier",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Nat Rev Microbiol",
            "volume": "6",
            "issn": "5",
            "pages": "349--62",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Normal structure, function, and histology of mucosaassociated lymphoid tissue",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Cesta",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Toxicol Pathol",
            "volume": "34",
            "issn": "5",
            "pages": "599--608",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Corr",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Gahan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hill",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "FEMS Immunol Med Microbiol",
            "volume": "52",
            "issn": "1",
            "pages": "2--12",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Mucosal vaccines: the promise and the challenge",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Neutra",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Kozlowski",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Nat Rev Immunol",
            "volume": "6",
            "issn": "2",
            "pages": "148--58",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Mucosal immunity and vaccines",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Holmgren",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Czerkinsky",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "4",
            "pages": "45--53",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Advantages and disadvantages of using live vaccines risks and control measures",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Alexandersen",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Acta Vet Scand Suppl",
            "volume": "90",
            "issn": "",
            "pages": "89--100",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Corthier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Recent Res Devel Microbiology",
            "volume": "8",
            "issn": "",
            "pages": "147--60",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hum Vaccin",
            "volume": "5",
            "issn": "4",
            "pages": "264--271",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Illum",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Davis",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Adv Drug Deliv Rev",
            "volume": "51",
            "issn": "1-3",
            "pages": "1--3",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Immunostimulating complexes (ISCOMs) for nasal vaccination",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "L\u00f6vgren-Bengtsson",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Morein",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Adv Drug Deliv Rev",
            "volume": "51",
            "issn": "1-3",
            "pages": "149--59",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Cationic liposomes as vaccine adjuvants",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Christensen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Korsholm",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Rosenkrands",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Expert Rev Vaccines",
            "volume": "6",
            "issn": "5",
            "pages": "785--96",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Nanoparticles and microparticles as vaccine-delivery systems",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chakrapani",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "O&apos;hagan",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Expert Rev Vaccines",
            "volume": "6",
            "issn": "5",
            "pages": "797--808",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Vaccinia virus: a tool for research and vaccine development",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moss",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Science",
            "volume": "252",
            "issn": "5013",
            "pages": "1662--1669",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Uses of vaccinia virus in vaccine delivery",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ulaeto",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Hruby",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Curr Opin Biotechnol",
            "volume": "5",
            "issn": "5",
            "pages": "501--505",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "The potential role of fowlpox virus in rational vaccine design",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Beukema",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Hayball",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Expert Rev Vaccines",
            "volume": "5",
            "issn": "4",
            "pages": "565--77",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Mucosal vaccine vectors: replicationcompetent versus replication-defi cient poxviruses",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "U"
                    ],
                    "last": "Karkhanis",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Ross",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Curr Pharm Des",
            "volume": "13",
            "issn": "",
            "pages": "2015--2038",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "The coming of age of virus-like particle vaccines",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "T"
                    ],
                    "last": "Jennings",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Bachmann",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Biol Chem",
            "volume": "389",
            "issn": "5",
            "pages": "521--557",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Patterson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Robert-Guroff",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Expert Opin Biol Ther",
            "volume": "8",
            "issn": "9",
            "pages": "1347--63",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Nasal vaccination using live bacterial vectors",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mielcarek",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Alonso",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Locht",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Adv Drug Deliv Rev",
            "volume": "51",
            "issn": "1-3",
            "pages": "55--69",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Use of attenuated bacteria as delivery vectors for DNA vaccines",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Daudel",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Weidinger",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Spreng",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Expert Rev Vaccines",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "New use of BCG for recombinant vaccines",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Stover",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "F"
                    ],
                    "last": "De La Cruz",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Fuerst",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Nature",
            "volume": "351",
            "issn": "6326",
            "pages": "456--60",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cellmediated immunity",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Jensen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "O"
                    ],
                    "last": "Wettstein",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Immunol Rev",
            "volume": "158",
            "issn": "",
            "pages": "147--57",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Recombinant Salmonella vectors in vaccine development",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Curtiss R 3rd",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Kelly",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Tinge",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Dev Biol Stand",
            "volume": "82",
            "issn": "",
            "pages": "23--33",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Bacterial mucosal vaccines: Vibrio cholera as a live attenuated vaccine/vector paradigm",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Killeen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Spriggs",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mekalanos",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "236",
            "issn": "",
            "pages": "237--54",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Live attenuated Shigella fl exneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Phalipon",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sansonetti",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Biologicals",
            "volume": "23",
            "issn": "2",
            "pages": "125--159",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Stevenson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Roberts",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "FEMS Immunol Med Microbiol",
            "volume": "37",
            "issn": "2-3",
            "pages": "121--129",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Oral colonization and immune responses to Streptococcus gordonii: Potential use as a vector to induce antibodies against respiratory pathogens",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Curr Opin Infect Dis",
            "volume": "16",
            "issn": "3",
            "pages": "231--236",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Lactobacilli as live vaccine delivery vectors: progress and prospects",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Seegers",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Trends Biotechnol",
            "volume": "20",
            "issn": "12",
            "pages": "508--523",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "N"
                    ],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hansson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "St\u00e5hl",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Gene",
            "volume": "128",
            "issn": "1",
            "pages": "89--94",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Holmgren",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Harandi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Czerkinsky",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Expert Rev Vaccines",
            "volume": "2",
            "issn": "2",
            "pages": "205--222",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Targeted vaccine adjuvants based on modifi ed cholera toxin",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Lycke",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Curr Mol Med",
            "volume": "5",
            "issn": "6",
            "pages": "591--598",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Cytokines as clinical adjuvants: how far are we?",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Villinger",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Expert Rev Vaccines",
            "volume": "2",
            "issn": "2",
            "pages": "317--343",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Cytokines as adjuvants for the induction of mucosal immunity",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "N"
                    ],
                    "last": "Boyaka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Mcghee",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Adv Drug Deliv Rev",
            "volume": "51",
            "issn": "1-3",
            "pages": "71--80",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "IL-12 as an adjuvant for the enhancement of protective humoral immunity",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Metzger",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Expert Rev Vaccines",
            "volume": "8",
            "issn": "5",
            "pages": "515--523",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Norton",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wells",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "FEMS Immunol Med Microbiol",
            "volume": "14",
            "issn": "2-3",
            "pages": "167--77",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Reveneau",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Geoffroy",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Locht",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Vaccine",
            "volume": "20",
            "issn": "",
            "pages": "1769--77",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Loir",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Med Microbiol",
            "volume": "53",
            "issn": "",
            "pages": "427--460",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Siegers",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "D"
                    ],
                    "last": "Entian",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Appl Environ Microbiol",
            "volume": "61",
            "issn": "3",
            "pages": "1082--1091",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Inducible gene expression systems in Lactococcus lactis",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Djordjevic",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Klaenhammer",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Mol Biotechnol",
            "volume": "9",
            "issn": "2",
            "pages": "127--166",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Heterologous protein production and delivery systems for Lactococcus lactis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nouaille",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Ribeiro",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Miyoshi",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Genet Mol Res",
            "volume": "2",
            "issn": "1",
            "pages": "102--113",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bolotin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wincker",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mauger",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Genome Res",
            "volume": "11",
            "issn": "5",
            "pages": "731--53",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Wegmann",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "O&apos;connell-Motherway",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zomer",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Bacteriol",
            "volume": "189",
            "issn": "8",
            "pages": "3256--70",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Isolation and characterization of Streptococcus cremoris Wg2-specifi c promoters",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Van Der Vossen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Van Der Lelie",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Venema",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Appl Environ Microbiol",
            "volume": "53",
            "issn": "10",
            "pages": "2452--2459",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "De Ruyter",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Pg",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Op Kuipers",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Beerthuyzen",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Bacteriol",
            "volume": "178",
            "issn": "",
            "pages": "3434--3473",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "P"
                    ],
                    "last": "Kuipers",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Beerthuyzen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "De Ruyter",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Biol Chem",
            "volume": "270",
            "issn": "45",
            "pages": "27299--304",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Mierau",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kleerebezem",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Appl Microbiol Biotechnol",
            "volume": "68",
            "issn": "6",
            "pages": "705--722",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Direct screening of recombinants in gram-positive bacteria using the secreted staphylococcal nuclease as a reporter",
            "authors": [
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Loir",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gruss",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ehrlich",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Bacteriol",
            "volume": "178",
            "issn": "14",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Functional analysis of the Lactococcus lactis usp45 secretion signal in the secretion of a homologous proteinase and a heterologous alpha-amylase",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Asseldonk",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "De Vos",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Simons",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Mol Gen Genet",
            "volume": "40",
            "issn": "",
            "pages": "428--434",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Protein secretion in Lactococcus lactis : an effi cient way to increase the overall heterologous protein production",
            "authors": [
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Loir",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Azevedo",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Oliveira",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Microb Cell Fact",
            "volume": "4",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Piard",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Hautefort",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Fischetti",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Bacteriol",
            "volume": "179",
            "issn": "9",
            "pages": "3068--72",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "D"
                    ],
                    "last": "Zegers",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kluter",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Van Der Stap",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Appl Microbiol",
            "volume": "87",
            "issn": "2",
            "pages": "309--323",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Oral immunization with recombinant Lactobacillus plantarum induces a protective immune response in mice with Lyme disease",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Del Rio",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Dattwyler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aroso",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Clin Vaccine Immunol",
            "volume": "15",
            "issn": "9",
            "pages": "1429--1464",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a fi rst step towards food-grade live vaccines against brucellosis",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Ribeiro",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Azevedo",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Loir",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Appl Environ Microbiol",
            "volume": "68",
            "issn": "2",
            "pages": "910--916",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Miyoshi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Ribeiro",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Microb Cell Fact",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Lactococcus lactis: highlevel expression of tetanus toxin fragment C and protection against lethal challenge",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wells",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Norton",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Mol Microbiol",
            "volume": "8",
            "issn": "6",
            "pages": "1155--62",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "Maassen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Laman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Den Bak-Glashouwer",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Vaccine",
            "volume": "17",
            "issn": "17",
            "pages": "2117--2145",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Grangette",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "M\u00fcller-Alouf",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Goudercourt",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Infect Immun",
            "volume": "69",
            "issn": "3",
            "pages": "1547--53",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Heterologous production and secretion of Clostridium perfringens beta-toxoid in closely related Gram-positive hosts",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nijland",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lindner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Hartskamp",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Biotechnol",
            "volume": "127",
            "issn": "3",
            "pages": "361--72",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Lactobacillus acidophilus expressing recombinant K99 adhesive fi mbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ha",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Microbiol Immunol",
            "volume": "49",
            "issn": "11",
            "pages": "941--949",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "I"
                    ],
                    "last": "Cheun",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kawamoto",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hiramatsu",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Appl Microbiol",
            "volume": "96",
            "issn": "6",
            "pages": "1347--53",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Roussel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wilks",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tabaqchali",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Vaccine",
            "volume": "19",
            "issn": "",
            "pages": "3927--3962",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Corth\u00e9sy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Boris",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Isler",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Infect Dis",
            "volume": "192",
            "issn": "8",
            "pages": "1441--1450",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "Y"
                    ],
                    "last": "Jun",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Appl Microbiol Biotechnol",
            "volume": "72",
            "issn": "3",
            "pages": "462--70",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Intragastric immunization with recombinant Lactobacillus casei expressing fl agellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kajikawa",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Satoh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Leer",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "18",
            "pages": "3599--605",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Iwaki",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Okahashi",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Takahashi",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "Infect Immun",
            "volume": "58",
            "issn": "9",
            "pages": "2929--2963",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mannam",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Geller",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Infect Immun",
            "volume": "72",
            "issn": "6",
            "pages": "3444--50",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Hanniffy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Carter",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Hitchin",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "195",
            "issn": "2",
            "pages": "185--93",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Oliveira",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Monedero",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "N"
                    ],
                    "last": "Miyaji",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "FEMS Microbiol Lett",
            "volume": "227",
            "issn": "1",
            "pages": "25--31",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Buccato",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Maione",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Rinaudo",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Infect Dis",
            "volume": "194",
            "issn": "3",
            "pages": "331--371",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Enouf",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Commissaire",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Corthier",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Appl Environ Microbiol",
            "volume": "67",
            "issn": "4",
            "pages": "1423--1431",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Mucosal immunization with surfacedisplayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Poo",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Han",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Virol",
            "volume": "80",
            "issn": "8",
            "pages": "4079--87",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specifi c antibody production",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kwang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "K"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Vaccine",
            "volume": "23",
            "issn": "11",
            "pages": "1335--1377",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sim",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "9",
            "pages": "1145--54",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Immunogenicity and protective effi cacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "Q"
                    ],
                    "last": "Xin",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hoshino",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Toda",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Blood",
            "volume": "102",
            "issn": "1",
            "pages": "223--231",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Production of human papillomavirus type 16 E7 protein in Lactococcus lactis",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Miyoshi",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Appl Environ Microbiol",
            "volume": "68",
            "issn": "2",
            "pages": "917--939",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specifi c antitumor effects in C57/BL6 mice",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Poo",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Pyo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Yoon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Sung",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Int J Cancer",
            "volume": "119",
            "issn": "7",
            "pages": "1702--1711",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Infl uence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lef\u00e8vre",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Corthier",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "36",
            "pages": "6581--6589",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "K"
                    ],
                    "last": "Han",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "47",
            "pages": "8049--57",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kharrat",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "BMC Res Notes",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Aires",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Cianciarullo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Carneiro",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Appl Environ Microbiol",
            "volume": "72",
            "issn": "1",
            "pages": "745--52",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Dieye",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Hoekman",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Clier",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Appl Environ Microbiol",
            "volume": "69",
            "issn": "12",
            "pages": "7281--7289",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kong",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Virol Methods",
            "volume": "150",
            "issn": "1-2",
            "pages": "1--6",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Appl Environ Microbiol",
            "volume": "73",
            "issn": "21",
            "pages": "7041--7048",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Perez",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Eichwald",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Burrone",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Appl Microbiol",
            "volume": "99",
            "issn": "5",
            "pages": "1158--64",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19)",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "H"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "J"
                    ],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "World J Gastroenterol",
            "volume": "11",
            "issn": "44",
            "pages": "6975--80",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ramasamy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yasawardena",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zomer",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine",
            "volume": "24",
            "issn": "18",
            "pages": "3900--3908",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Chatel",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                },
                {
                    "first": "Adel-Patient",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Clin Diagn Lab Immunol",
            "volume": "8",
            "issn": "3",
            "pages": "545--51",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Constitutive delivery of bovine beta-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hazebrouck",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Oozeer",
                    "suffix": ""
                },
                {
                    "first": "Adel-Patient",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Appl Environ Microbiol",
            "volume": "72",
            "issn": "12",
            "pages": "7460--7467",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Inhibition of allergen-induced airway infl ammation and hyperreactivity by recombinant lactic-acid bacteria",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Charng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Hsu",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine",
            "volume": "24",
            "issn": "",
            "pages": "5931--5937",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Oral immunization of BALB/c mice by intragastric delivery of Streptococcus gordonii-expressing Giardia cyst wall protein 2 decreases cyst shedding in challenged mice",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Faubert",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "FEMS Microbiol Lett",
            "volume": "265",
            "issn": "2",
            "pages": "225--261",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Steidler",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chamberlain",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Infect Immun",
            "volume": "66",
            "issn": "7",
            "pages": "3183--3192",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Treatment of murine colitis by Lactococcus lactis secreting interleukin-10",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Steidler",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hans",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Schotte",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Science",
            "volume": "289",
            "issn": "5483",
            "pages": "1352--1357",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Biological containment of genetically modifi ed Lactococcus lactis for intestinal delivery of human interleukin 10",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Steidler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Neirynck",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Huyghebaert",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat Biotechnol",
            "volume": "21",
            "issn": "7",
            "pages": "785--794",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specifi c Th1 cytokine production",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Infect Immun",
            "volume": "71",
            "issn": "4",
            "pages": "1887--96",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Controlled intra-or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langella",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Commissaire",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "FEMS Microbiol Lett",
            "volume": "224",
            "issn": "2",
            "pages": "307--320",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Production of biological active murine IFN-gamma by recombinant Lactococcus lactis",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "&apos;haridon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "FEMS Microbiol Lett",
            "volume": "280",
            "issn": "2",
            "pages": "144--153",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Expression of bioactive porcine interferon-gamma by recombinant Lactococcus lactis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Rupa",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Monedero",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "N"
                    ],
                    "last": "Wilkie",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vet Microbiol",
            "volume": "129",
            "issn": "1-2",
            "pages": "197--202",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Secretion of human interferon-beta 1b by recombinant Lactococcus lactis",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhuang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "G"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Biotechnol Lett",
            "volume": "30",
            "issn": "10",
            "pages": "1819--1842",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "Costa",
                    "middle": [],
                    "last": "Da",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "F"
                    ],
                    "last": "Medina",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lef\u00e8vre",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "46",
            "pages": "5778--83",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nouaille",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Zilberfarb",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Appl Environ Microbiol",
            "volume": "73",
            "issn": "16",
            "pages": "5300--5307",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "A nine-residue synthetic propeptide enhances secretion effi ciency of heterologous proteins in Lactococcus lactis",
            "authors": [
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Loir",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gruss",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ehrlich",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Bacteriol",
            "volume": "180",
            "issn": "7",
            "pages": "1895--903",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Complementation of the Lactococcus lactis secretion machinery with Bacillus subtilis SecDF improves secretion of staphylococcal nuclease",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nouaille",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Morello",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cortez-Peres",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Appl Environ Microbiol",
            "volume": "72",
            "issn": "3",
            "pages": "2272--2281",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Poquet",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Saint",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Seznec",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Mol Microbiol",
            "volume": "35",
            "issn": "5",
            "pages": "1042--51",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "ClpP participates in the degradation of misfolded protein in Lactococcus lactis",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Frees",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ingmer",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Mol Microbiol",
            "volume": "31",
            "issn": "1",
            "pages": "79--87",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Construction and characterization of a Lactococcus lactis strain defi cient in intracellular ClpP and extracellular HtrA proteases",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Poquet",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Oliveira",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Microbiology",
            "volume": "152",
            "issn": "",
            "pages": "2611--2619",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Norton",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wells",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "FEMS Immunol Med Microbiol",
            "volume": "14",
            "issn": "2-3",
            "pages": "167--77",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Oral vaccination of mice against tetanus with recombinant Lactococcus lactis",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Chamberlain",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Schofi Eld",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Nat Biotechnol",
            "volume": "15",
            "issn": "7",
            "pages": "653--660",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Natural history and epidemiology of HPV infection and cervical cancer",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Castellsagu\u00e9",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Gynecol Oncol",
            "volume": "110",
            "issn": "",
            "pages": "4--7",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Schiller",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Castellsagu\u00e9",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Villa",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "10",
            "pages": "53--61",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lef\u00e8vre",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Immunol",
            "volume": "175",
            "issn": "11",
            "pages": "7297--302",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Braat",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Rottiers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Hommes",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Gastroenterol Hepatol",
            "volume": "4",
            "issn": "6",
            "pages": "754--763",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "Clinical practice. Food allergy",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lack",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "359",
            "issn": "12",
            "pages": "1252--60",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "A: Cytokines induce the development of functionally heterogeneous T helper cell subsets",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "O&apos;garra",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Immunity",
            "volume": "8",
            "issn": "",
            "pages": "275--83",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge",
            "authors": [
                {
                    "first": "Adel-Patient K",
                    "middle": [],
                    "last": "Nahori",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Proust",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Clin Exp Allergy",
            "volume": "33",
            "issn": "3",
            "pages": "376--85",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ah-Leung",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clin Vaccine Immunol",
            "volume": "14",
            "issn": "3",
            "pages": "226--259",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Cortes-Perez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ah-Leung",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Int Arch Allergy Immunol",
            "volume": "150",
            "issn": "1",
            "pages": "25--31",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Int Immunopharmacol",
            "volume": "6",
            "issn": "4",
            "pages": "610--615",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Lactobacilli: vehicles for antigen delivery to the female urogenital tract",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Rush",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Hafner",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Timms",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Adv ExpMed Biol",
            "volume": "371",
            "issn": "",
            "pages": "1547--52",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Pouwels",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Leer",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Boersma",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Biotechnol",
            "volume": "44",
            "issn": "1-3",
            "pages": "183--92",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Production of a heterologous nonheme catalase by Lactobacillus casei: an effi cient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Rochat",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Gratadoux",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gruss",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Appl Environ Microbiol",
            "volume": "72",
            "issn": "8",
            "pages": "5143--5152",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Antiinfl ammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Rochat",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Berm\u00fadez-Humar\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Gratadoux",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Microb Cell Fact",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Simpson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Proc Natl Acad Sci",
            "volume": "100",
            "issn": "20",
            "pages": "11672--11679",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "In situ delivery of passive immunity by lactobacilli producing single-chain antibodies",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kr\u00fcger",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Nat Biotechnol",
            "volume": "20",
            "issn": "7",
            "pages": "702--708",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": []
}